Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$552K Sell
50,802
-513
-1% -$5.48K ﹤0.01% 1058
2026
Q1
$570K Buy
51,315
+11,911
+30% +$152K ﹤0.01% 962
2025
Q4
$646K Buy
39,404
+19,252
+96% +$300K ﹤0.01% 838
2025
Q3
$270K Sell
20,152
-1,573
-7% -$18.6K ﹤0.01% 1217
2025
Q2
$278K Sell
21,725
-32,521
-60% -$390K ﹤0.01% 1172
2025
Q1
$559K Buy
54,246
+1,054
+2% +$13.6K 0.01% 900
2024
Q4
$676K Buy
53,192
+2,630
+5% +$34.8K 0.01% 856
2024
Q3
$647K Sell
50,562
-17,551
-26% -$215K 0.01% 850
2024
Q2
$864K Buy
68,113
+7,517
+12% +$130K 0.01% 721
2024
Q1
$1.37M Buy
60,596
+17,313
+40% +$405K 0.01% 637
2023
Q4
$1.08M Sell
43,283
-1,563
-3% -$30.5K 0.01% 643
2023
Q3
$767K Buy
44,846
+1,694
+4% +$28.2K 0.01% 734
2023
Q2
$715K Buy
43,152
+26,910
+166% +$432K 0.01% 769
2023
Q1
$285K Sell
16,242
-805
-5% -$12.2K ﹤0.01% 1051
2022
Q4
$217K Buy
17,047
+6,226
+58% +$76.9K ﹤0.01% 1108
2022
Q3
$136K Buy
10,821
+777
+8% +$13.6K ﹤0.01% 1105
2022
Q2
$183K Buy
+10,044
New +$188K ﹤0.01% 1102

Other funds holding PATH

Xponance's PATH Position: Q2 2026 in Review

Xponance reduced its UiPath (PATH) stake by 1% in Q2 2026, selling an estimated $5.48K and leaving 50,802 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Xponance first reported a position in PATH in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.37M in Q1 2024. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Xponance held 50,802 shares of UiPath worth $552K as of Q2 2026.
  • Xponance sold 513 UiPath shares in Q2 2026, an estimated $5.48K.
  • UiPath made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1058 holding.
  • Xponance first reported a position in UiPath in Q2 2022 and has held it in 17 quarters since.
  • Xponance's UiPath position peaked at $1.37M in Q1 2024.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.